BMJ Oncology says AI is becoming a new commercial determinant of health
zakkohane · x · 2026-07-23
A BMJ Oncology piece argues that artificial intelligence is becoming a new commercial determinant of health.
The framing suggests AI is no longer just a clinical tool: it can shape access, incentives, and the economics around healthcare, making it part of the broader commercial forces that affect health outcomes.
More from AGI Musings
- AI staff should rethink the “RSI means winner-take-all” narrative — herbiebradley · 2026-07-23
- Agents are being given full system and web access before behavior is truly contained — paraschopra · 2026-07-23
- AI writing without AI is, in this view, no longer a credible position — PawelHuryn · 2026-07-23
- Essay argues AI may kill jobs without creating more free time — whoamisri · 2026-07-23
- Jensen Huang calls AI consciousness claims “complete nonsense” in a policy interview — RileyRalmuto · 2026-07-23
- Model release speed is making academic paper writing feel lopsided — xeophon · 2026-07-23